Current evidence indicates that BSP enhances breast and prostate cancer cell survival through RGD-integrin MEK/ERK signalling and facilitates anoikis resistance in lung cancer via miR-150-5p/MMP-14, ultimately supporting metastatic colonisation. This evidence concerns the gene IBSP and lung cancer.